Answer
Lazcluze (lazertinib) has no or negligible influence on driving or using machines, but patients with treatment-related symptoms such as fatigue affecting concentration and reactions should not drive or use machines until these effects subside.
Sources for this answer
- Lazcluze 80 mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 3Document updated
Sources checked